BioCentury
ARTICLE | Company News

Dr. Falk Pharma, Salix deal

March 17, 2008 7:00 AM UTC

Dr. Falk granted Salix an exclusive license to develop and commercialize budesonide products in the U.S. The products include budesonide rectal foam, which is expected to start Phase III testing late...